1-2 of 2
Jenna Mahns
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glofitamab and obinutuzumab (GLOBIN) as first-line therapy for patients with high-tumor burden follicular lymphoma: First results of a multicenter phase II trial

Free
Reid Merryman, Gottfried von Keudell, Robert Redd, Heather Walker, Jenna Mahns, Samantha Normilus, Siri Sagedahl, Ioulia Vogiatzi, Mingzeng Zhang, Emily Sumpena, Weihsin Chuan, Inhye Ahn, Amy Bessnow, Jennifer Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Hua-Jay Cherng, Mark Murakami, Philippe Armand, Joshua Brody
Journal: Blood
Blood (2025) 146 (Supplement 1): 3602.
https://doi.org/10.1182/blood-2025-3602
Published: 2025
Journal Articles

Immune population changes after glofitamab and obinutuzumab (GLOBIN) as first-line therapy for patients with follicular lymphoma and marginal zone lymphoma

Free
Emily Sumpena, Ioulia Vogiatzi, Arsh Patel, Heather Walker, Jenna Mahns, Robert Redd, Philippe Armand, Reid Merryman, Mark Murakami
Journal: Blood
Blood (2025) 146 (Supplement 1): 5344.
https://doi.org/10.1182/blood-2025-5344
Published: 2025